期刊文献+

动脉僵硬度和骨保护素对稳定型冠状动脉疾病患者的预后评估 被引量:1

Prognostic Value of Arterial Stiffness and Osteoprotegerin in Patients with Stable Coronary Artery Disease
下载PDF
导出
摘要 目的探讨动脉僵硬度和骨保护素对稳定型冠状动脉疾病(stable coronary artery disease,SCAD)患者预后的预测价值。方法回顾性选择在我院接受冠状动脉介入治疗的SCAD患者160例作为研究对象。根据随访期间有无主要不良心血管事件(major adverse cardiovascular events,MACE)发生分为MACE发生组(n=70)和MACE未发生组(n=90)。比较两组患者在临床特征方面的差异。通过绘制受试者工作特征曲线(receiver operating characteristic curve,ROC),筛选切点,计算曲线下面积评估不同参数预测SCAD患者MACE发生效力。应用多因素非条件Logistic回归分析影响SCAD患者MACE发生的危险性因素。结果MACE未发生组左心室射血分数高于MACE发生组,Gensini评分、脉搏波速度(pulse wave velocity,PWV)、骨保护素水平低于MACE发生组,差异有统计学意义(均P<0.05)。左心室射血分数、Gensini评分、PWV、骨保护素预测SCAD患者MACE发生的诊断界值分别为50.00%、32.35分、8.85m/s、3.78pmol/L(均P<0.05)。多因素Logistic回归分析结果显示,Gensini评分≥32.35分、PWV≥8.85m/s、骨保护素≥3.78pmol/L增加SCAD患者MACE发生风险(OR=3.72~3.85,均P<0.05)。结论Gensini评分、PWV、骨保护素水平与SCAD患者MACE发生密切相关。PWV和骨保护素水平偏高不利于SCAD患者预后。 Objective To investigate the prognostic role of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease(SCAD).Methods 160 patients with SCAD received coronary intervention therapy in our hospital were selected.The patients were divided into MACE group(n=70)and non-MACE group(n=90)according to whether MACE happened or not during the follow-up period.The differences in clinical characteristics between the two groups were compared.The ROC curve was drawn,the cut points were selected,the area under the curve was calculated,and the different parameters were used to predict the effectiveness of MACE in SCAD patients.Multivariate logistic regression analysis was used to analyze the risk factors of MACE in SCAD patients.Results The left ventricular ejection fraction in non-MACE group was higher than that in MACE group,while Gensini score,PWV,and osteoprotegerin were lower than those in MACE group,the difference were statistically significant(P<0.05).The diagnostic values of left ventricular ejection fraction,Gensini score,PWV and osteoprotegerin in predicting the occurrence of MACE in SCAD patients were 50.00%,32.35 points,8.85 m/s and 3.78 pmol/L,respectively(P<0.05).The results of multiple factor logistic regression analysis showed that the Gensini score≥32.35 points,PWV≥8.85 m/s,and osteoprotegerin≥3.78 pmol/L increased the risk of MACE occur in SCAD patients(OR=3.72~3.85,P<0.05).Conclusions Gensini score,PWV and osteoprotegerin are closely related to MACE in SCAD patients.The high level of PWV and osteoprotegerin is bad for the prognosis of SCAD patients.
作者 延喜悦 黄永华 YAN Xiyue;HUANG Yong-hua(Department of Cardiology,Yulin First Hospital,Shaanxi 718000,China)
出处 《心脑血管病防治》 2019年第4期311-314,共4页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 动脉僵硬度 骨保护素 稳定型冠状动脉疾病 主要不良心血管事件 Arterial stiffness Osteoprotegerin Stable coronary artery disease Major adverse cardiovascular events
  • 相关文献

参考文献4

二级参考文献26

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2032
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2057
  • 3Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:e354-e471.
  • 4Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:3097-3137.
  • 5Task force members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology[J].Eur Heart J, 2013,34:2949-3003.
  • 6Qaseem A, Fihn SD, Williams S, et al.Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons[J].Ann Intern Med 2012;157:729-734.
  • 7严子君,张瑞岩,左君丽,张奇,初少莉,沈卫峰.多种大动脉僵硬度指标的联合应用对冠心病预测价值的研究[J].中华老年心脑血管病杂志,2010,12(1):23-26. 被引量:6
  • 8杨志霞,林谦,马利.丹参对心血管疾病药理作用的文献研究[J].世界中西医结合杂志,2012,7(2):93-96. 被引量:188
  • 9黄晓春.高血压患者血管僵硬度与心功能相互关系初步研究[J].实用医技杂志,2012,19(10):1055-1056. 被引量:2
  • 10秦海凤,刘新灿,朱翠玲,孙彦琴.颈动脉内膜-中膜厚度与冠状动脉硬化的关系[J].中国老年学杂志,2012,32(21):4628-4629. 被引量:8

共引文献221

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部